Patients with pancreatic cancer show the lowest 5-year survival rate among all other cancers, which is initiated by various genetic alterations; however, K-Ras is the most commonly implicated gene in pancreatic adenocarcinoma, with a 70–90% contribution. This evidence concerns the gene KRAS and pancreatic neoplasm.